Month: September 2020

DURHAM, Caroline du Nord, et PARIS, 17 sept. 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq : DTIL), une société biotechnologique en phase clinique développant des traitements par correction génique in vivo et à base de cellules CAR T allogéniques avec sa plateforme d’édition de génomes ARCUS®, en collaboration avec Servier, une société pharmaceutique mondiale indépendante, a annoncé aujourd’hui que les sociétés avaient ajouté deux cibles supplémentaires pour le cancer hématologique au-delà de la protéine CD19 ainsi que deux cibles de tumeurs solides à son accord de développement et de licence commerciale concernant son traitement à base de cellules CAR T.« L’ajout de ces nouvelles cibles s’appuiera sur la collaboration fructueuse de plusieurs années entre Precision et Servier qui stimule le...

DURHAM, N.C. und PARIS, Sept. 17, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), ein Biotechnologieunternehmen im Bereich der klinischen Forschung, das in Zusammenarbeit mit Servier, einem internationalen Pharmaunternehmen, allogene CAR-T- und In-vivo-Gentherapien mit seiner Genom-Editierplattform ARCUS® entwickelt, gab heute bekannt, dass die Unternehmen neben CD19 zwei weitere hämatologische Krebsziele sowie zwei Ziele für solide Tumore in ihre CAR-T-Entwicklungs- und -Vermarktungs-Lizenzvereinbarung aufgenommen haben.„Die Aufnahme dieser neuen Targets baut auf der produktiven mehrjährigen Zusammenarbeit von Precision und Servier auf, die die Entwicklung von PBCAR0191, unserem führenden, auf CD19 abzielenden, allogenen CAR-T-Kandidaten voranbringt“, so Matt Kane, CEO und Mitgründer von Precision BioSciences....

CARLSBAD, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) — Acutus Medical (Nasdaq: AFIB) today announces FDA 510(k) clearance of the second-generation AcQMap® 3D imaging and mapping catheter which builds on its predecessor, improving handling and deliverability. This flagship 3D mapping and navigation catheter combines 48 ultrasound transducers responsible for creating the anatomical geometry and 48 engineered electrodes which enable electrical activation patterns to be displayed along the inner surface of the heart. Compatible with an 0.035” guidewire, the AcQMap catheter is designed to be inserted into the left and right atrium.The AcQMap catheter is the cornerstone of Acutus’ innovative mapping platform. It is the world’s only integrated high-resolution ultrasound-based imaging and non-contact mapping catheter capable of capturing cardiac...

CARLSBAD, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today reported financial results for its second quarter ended June 30, 2020.Recent Highlights:Reported revenue of $1.1 million in the second quarter of 2020, a 54% increase over the same quarter last year and within the preliminary range disclosed in our initial public offering (“IPO”) prospectus.Increased worldwide installed base of AcQMap consoles to 38 as of June 30, 2020, up from 31 at the end of the prior quarter. Of those 38 consoles, 21 were 2nd generation machines, up from 11 at the end of the prior quarter.During August, completed an initial public offering of 10.1 million shares, raising $163.3 million in net proceeds.“In light of the challenging circumstances experienced by medical device companies generally during the...

IRVINE, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the promotion of Drew Hykes to Chief Operating Officer, effective September 1, 2020.  In his expanded role, Mr. Hykes will now have responsibility for Research, Product Development, Manufacturing, Operations, Quality and Regulatory, in addition to the Commercial functions.Mr. Hykes joined Inari as Chief Commercial Officer in September 2017.  Prior to Inari, Mr. Hykes served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market....

New York, NY, Sept. 17, 2020 (GLOBE NEWSWIRE) — Software Acquisition Group Inc. II (NASDAQ: SAIIU) (the “Company”) announced today that it closed its initial public offering of 15,000,000 units. The offering was priced at $10.00 per unit, resulting in gross proceeds of $150,000,000. The Company granted the underwriters in the initial public offering, a 45-day option to purchase up to 2,250,000 additional units solely to cover over-allotments, if any.The Company’s units are listed on the Nasdaq Capital Market (“Nasdaq”) and commenced trading under the ticker symbol “SAIIU” on September 15, 2020. Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only...

PLANTATION, FL, Sept. 17, 2020 (GLOBE NEWSWIRE) — LMP Automotive Holdings, Inc. (NASDAQ:LMPX) (the “Company”), an e-commerce and facilities-based platform for consumers who desire to buy, sell, subscribe for or finance pre-owned and new automobiles, today announced its Interactive Subscription Leasing E-commerce App – LMP MOTORS –  is now available in the Apple App and Google Play Stores.Sam Tawfik, the Company’s Chairman and Chief Executive Officer commented, “We see the immense opportunity that exists within our industry that we are exploiting through continued focused growth and the activation of our e-commerce sales, subscription, and dealership acquisition strategy. We are seeing a robust acquisition market as we continue to build our pipeline of prospective dealership acquisitions and intend on accelerating...